Oral domperidone versus placebo for enhancing exclusive breastfeeding among post-lower segment cesarean section mothers - a double-blind randomized controlled trial
OBJECTIVE: To assess whether oral domperidone compared to placebo increases the rate of exclusive breastfeeding for 6 months among post-lower segment cesarean section (LSCS) mothers.
METHODS: This double-blind Randomized Controlled Trial, conducted in a tertiary care teaching hospital in South India, included 366 post-LSCS mothers with delayed initiation of breastfeeding or with subjective feelings of not having enough milk. They were randomized to two groups - Group A: Standard lactation counseling and oral Domperidone and Group B: Standard lactation counseling and a placebo. The primary outcome was an exclusive breastfeeding rate at 6 months. Exclusive breastfeeding rates at 7 days and 3 months and serial weight gain of an infant were assessed in both groups.
RESULTS: Exclusive breastfeeding rate at 7 days was statistically significant in the intervention arm. The exclusive breastfeeding rates at 3 months and 6 months were higher in the domperidone arm compared to placebo but not statistically significant.
CONCLUSION: Oral Domperidone along with effective breastfeeding counseling showed an increasing trend of exclusive breastfeeding rate at 7 days and at six months. Appropriate breastfeeding counseling and postnatal lactation support are important in enhancing exclusive breastfeeding.
TRIAL REGISTRATION: The study was prospectively registered with CTRI - Reg no. CTRI/2020/06/026237.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
---|---|
Enthalten in: |
The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians - 36(2023), 1 vom: 10. Dez., Seite 2185754 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Archana, Arumugom [VerfasserIn] |
---|
Links: |
---|
Themen: |
5587267Z69 |
---|
Anmerkungen: |
Date Completed 06.03.2023 Date Revised 06.03.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1080/14767058.2023.2185754 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353696447 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM353696447 | ||
003 | DE-627 | ||
005 | 20231226060612.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/14767058.2023.2185754 |2 doi | |
028 | 5 | 2 | |a pubmed24n1178.xml |
035 | |a (DE-627)NLM353696447 | ||
035 | |a (NLM)36863712 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Archana, Arumugom |e verfasserin |4 aut | |
245 | 1 | 0 | |a Oral domperidone versus placebo for enhancing exclusive breastfeeding among post-lower segment cesarean section mothers - a double-blind randomized controlled trial |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.03.2023 | ||
500 | |a Date Revised 06.03.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To assess whether oral domperidone compared to placebo increases the rate of exclusive breastfeeding for 6 months among post-lower segment cesarean section (LSCS) mothers | ||
520 | |a METHODS: This double-blind Randomized Controlled Trial, conducted in a tertiary care teaching hospital in South India, included 366 post-LSCS mothers with delayed initiation of breastfeeding or with subjective feelings of not having enough milk. They were randomized to two groups - Group A: Standard lactation counseling and oral Domperidone and Group B: Standard lactation counseling and a placebo. The primary outcome was an exclusive breastfeeding rate at 6 months. Exclusive breastfeeding rates at 7 days and 3 months and serial weight gain of an infant were assessed in both groups | ||
520 | |a RESULTS: Exclusive breastfeeding rate at 7 days was statistically significant in the intervention arm. The exclusive breastfeeding rates at 3 months and 6 months were higher in the domperidone arm compared to placebo but not statistically significant | ||
520 | |a CONCLUSION: Oral Domperidone along with effective breastfeeding counseling showed an increasing trend of exclusive breastfeeding rate at 7 days and at six months. Appropriate breastfeeding counseling and postnatal lactation support are important in enhancing exclusive breastfeeding | ||
520 | |a TRIAL REGISTRATION: The study was prospectively registered with CTRI - Reg no. CTRI/2020/06/026237 | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Exclusive breastfeeding | |
650 | 4 | |a cesarean section | |
650 | 4 | |a domperidone | |
650 | 4 | |a galactagogues | |
650 | 4 | |a lactation counseling | |
650 | 7 | |a Domperidone |2 NLM | |
650 | 7 | |a 5587267Z69 |2 NLM | |
700 | 1 | |a Adhisivam, Bethou |e verfasserin |4 aut | |
700 | 1 | |a Chaturvedula, Latha |e verfasserin |4 aut | |
700 | 1 | |a Subramanian, Sadhana |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians |d 2002 |g 36(2023), 1 vom: 10. Dez., Seite 2185754 |w (DE-627)NLM121648222 |x 1476-4954 |7 nnns |
773 | 1 | 8 | |g volume:36 |g year:2023 |g number:1 |g day:10 |g month:12 |g pages:2185754 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/14767058.2023.2185754 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 36 |j 2023 |e 1 |b 10 |c 12 |h 2185754 |